A joint conference of the European Medical and Biological Engineering Conference (EMBEC) and the Nordic-Baltic Conference on Biomedical Engineering and Medical Physics (NBC) was held in Tampere, Finland on the 11-15 June. The event is one of a kind and the largest event in its area in Europe with over 600 participants from 50 countries. Finnish governmental organization, Finpro was at the event introducing it’s invest in Finland services as well as Finland Health program. Finpro’s Enterprise Europe Network arranged a networking event for international players.
One of the key note speakers at the event was Nobel prize winner in chemistry, Dr. Stefan W. Hell. He pioneered the physical concepts for breaking the diffraction barrier in a microscope using conventional lenses. His innovations include development of STED microscopy and related concepts and discovery of the on-off switching of (fluorescence) signal as key mechanism for overcoming the diffraction resolution limit.
EMBEC’17 & NBC’17 was a platform for engineers, physicists, biologists, and clinical experts to enhance knowledge and scientific achievements. The exhibition area provided possibilities for businesses and academia to meet. Finnish start-ups were recognized with a special showcase area. Also well-established and international companies were introducing their innovations. See the list here: http://embec2017.org/confirmed-sponsors-and-exhibitors/
- We aim to also highlight new emerging fields, such as tissue engineering, bioinformatics, biosensing, neurotechnology, additive manufacturing technologies for medicine and biology, and bioimaging, to name a few. Moreover, we will emphasize the role of education, translational research, and commercialization says Jari Hyttinen, Chair of the EMBEC’17 & NBC’17 Conference
The main organizer of the event was BioMediTech that conducts world-class basic and translational research in biomedicine and medical technology. Its research activities cover for example, biomaterials, stem cells, cancer, immunology, biosensors, imaging, and computational methods, with a common aim of developing personalized medicine via new diagnostic and treatment methods.